Viral Intrusion: Unveiling the Role of Human Papillomavirus in Primary Lung Cancer – A Systematic Review and Meta-analysis
DOI:
https://doi.org/10.36497/respirsci.v7i1.258Keywords:
carcinogenes, human papillomavirus, lung cancer, meta-analysisAbstract
Background: The role of human papillomavirus (HPV) in lung carcinogenesis remains debated. This systematic review and meta-analysis evaluated the association between HPV infection and lung cancer risk, as well as its potential prognostic implications.
Method: A systematic search of PubMed, ScienceDirect, and Google Scholar (2015–2025) identified observational studies reporting HPV status in both lung cancer cases and non-cancer controls. Pooled odds ratios (ORs) with 95% confidence intervals (CIs) were calculated using a random-effects model. Assessment of heterogeneity was performed using the I² statistic, and publication bias was examined using a funnel plot and Egger’s test. Studies lacking control groups or effect sizes were narratively summarized.
Results: Nine studies (n=3,871,842) were included, yielding a pooled OR of 2.62 (95% CI=1.86–3.68), indicating higher odds of lung cancer among HPV-infected individuals. Substantial heterogeneity was observed (I²=83.3%; P<0.001), and publication bias was detected (Egger’s test P=0.015). An additional 26 studies were narratively synthesized, many detecting HPV DNA mainly types 16 and 18 in lung tumors, particularly among non-smokers, females, and EGFR-mutated adenocarcinomas. Considerable variation in geographic origin, histology, detection method, and specimen type was also observed.
Conclusion: HPV infection is significantly associated with an increased risk of lung cancer, suggesting its possible role as a risk and prognostic biomarker. However, the presence of publication bias and heterogeneity underscores the need for further large-scale, standardized studies to validate these findings.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Respiratory Science

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.









